United States
KolateAI PharmaTech Inc, founded in 2023, is a United States-based startup emerging as a pioneer in the pharmaceutical industry. Their core offering, a Patient-level Outcome Prediction and Simulation Platform, revolutionizes drug trial processes by allowing pharmaceutical companies to simulate and predict individualized patient drug responses more accurately and inexpensively.
The platform's technology, which integrates complete patient histories from fragmented data sources, utilizes disease-specific models to create digital twins—virtual representations of patients. It has been validated in 11 studies, demonstrating over 90% accuracy in predicting clinical outcomes, with two scientific publications already accepted and five more under review.
Currently serving five global biopharmaceutical companies and three academic medical centers across various therapeutic areas, KolateAI PharmaTech Inc is set for expansion into neurology and pulmonology by 2026. The company recently secured a $150.00K Seed Round on 08 January 2024, driven by Entrepreneurs Roundtable Accelerator, underscoring investor confidence in their innovation and market potential.
